Ettinger D - Search Results

1

Phase I trial of weekly trabectedin (ET-743) and gemcitabine in patients with advanced solid tumors.

Messersmith WA, Jimeno A, Ettinger D, Laheru D, Brahmer J, Lansey D, Khan Y, Donehower RC, Elsayed Y, Zannikos P, Hidalgo M. Messersmith WA, et al. Among authors: ettinger d. Cancer Chemother Pharmacol. 2008 Dec;63(1):181-8. doi: 10.1007/s00280-008-0733-7. Epub 2008 Apr 1. Cancer Chemother Pharmacol. 2008. PMID: 18379785 Free PMC article. Clinical Trial.

2

Gemcitabine and vinorelbine in recurrent advanced non-small cell lung cancer: sequence does matter.

Juergens R, Brahmer J, Ettinger D. Juergens R, et al. Among authors: ettinger d. Cancer Chemother Pharmacol. 2007 Apr;59(5):621-9. doi: 10.1007/s00280-006-0304-8. Epub 2006 Aug 26. Cancer Chemother Pharmacol. 2007. PMID: 16937106 Clinical Trial.

3

A phase I trial of trimetrexate glucuronate (NSC 352122) given every 3 weeks: clinical pharmacology and pharmacodynamics.

Grochow LB, Noe DA, Ettinger DS, Donehower RC. Grochow LB, et al. Among authors: ettinger ds. Cancer Chemother Pharmacol. 1989;24(5):314-20. doi: 10.1007/BF00304765. Cancer Chemother Pharmacol. 1989. PMID: 2758561

4

A phase I trial of spirohydantoin mustard (NSC 172112) in patients with advanced cancer.

Brown TD, Ettinger DS, Donehower RC. Brown TD, et al. Among authors: ettinger ds. J Clin Oncol. 1986 Aug;4(8):1270-6. doi: 10.1200/JCO.1986.4.8.1270. J Clin Oncol. 1986. PMID: 3525770 Clinical Trial.

5

Dual inhibition of the epidermal growth factor receptor pathway with cetuximab and erlotinib: a phase I study in patients with advanced solid malignancies.

Guarino MJ, Schneider CJ, Hosford MA, Brahmer JR, Rudin CM, Finckenstein FG, Philip-Norton RE, Lu H, Weber MR, Ettinger DS. Guarino MJ, et al. Oncologist. 2009 Feb;14(2):119-24. doi: 10.1634/theoncologist.2008-0124. Epub 2009 Jan 31. Oncologist. 2009. PMID: 19182243 Free PMC article. Clinical Trial.

6

Phase I trial of taxol in patients with advanced cancer.

Donehower RC, Rowinsky EK, Grochow LB, Longnecker SM, Ettinger DS. Donehower RC, et al. Among authors: ettinger ds. Cancer Treat Rep. 1987 Dec;71(12):1171-7. Cancer Treat Rep. 1987. PMID: 2891441

7

A phase I study of menogaril in patients with advanced cancer.

Brown TD, Donehower RC, Grochow LB, Rice AP, Ettinger DS. Brown TD, et al. Among authors: ettinger ds. J Clin Oncol. 1987 Jan;5(1):92-9. doi: 10.1200/JCO.1987.5.1.92. J Clin Oncol. 1987. PMID: 2949065

8

Phase I study of N-methylformamide in patients with advanced cancer.

Ettinger DS, Orr DW, Rice AP, Donehower RC. Ettinger DS, et al. Cancer Treat Rep. 1985 May;69(5):489-93. Cancer Treat Rep. 1985. PMID: 4005871

9

Phase II study of pemetrexed-gemcitabine combination in patients with advanced-stage non-small cell lung cancer.

Monnerat C, Le Chevalier T, Kelly K, Obasaju CK, Brahmer J, Novello S, Nakamura T, Liepa AM, Bozec L, Bunn PA Jr, Ettinger DS. Monnerat C, et al. Clin Cancer Res. 2004 Aug 15;10(16):5439-46. doi: 10.1158/1078-0432.CCR-04-0218. Clin Cancer Res. 2004. PMID: 15328182 Clinical Trial.

10

Phase I and pharmacodynamic study of taxol in refractory acute leukemias.

Rowinsky EK, Burke PJ, Karp JE, Tucker RW, Ettinger DS, Donehower RC. Rowinsky EK, et al. Among authors: ettinger ds. Cancer Res. 1989 Aug 15;49(16):4640-7. Cancer Res. 1989. PMID: 2568175

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

345 results

Search Page

Filters